Evidence map›Paper›PMID 35703350›Full record

ArticleOncology reports2022

[Corrigendum] Role of 4‑aminobutyrate aminotransferase (ABAT) and the lncRNA co‑expression network in the development of myelodysplastic syndrome.

Yanzhen Chen, Guangjie Zhao, Nianyi Li, Zhongguang Luo, Xiaoqin Wang, Jingwen Gu

Abstract readPublished Erratum
In one paragraph

Article in Oncology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Yanzhen ChenWorldWide Medical Center, Huashan Hospital of Fudan University, Shanghai 200040, P.R. China.
Guangjie ZhaoDepartment of Hematology, Huashan Hospital of Fudan University, Shanghai 200040, P.R. China.
Nianyi LiDepartment of Hematology, Huashan Hospital of Fudan University, Shanghai 200040, P.R. China.
Zhongguang LuoDepartment of Digestive Diseases, Huashan Hospital of Fudan University, Shanghai 200040, P.R. China.
Xiaoqin WangDepartment of Hematology, Huashan Hospital of Fudan University, Shanghai 200040, P.R. China.
Jingwen GuWorldWide Medical Center, Huashan Hospital of Fudan University, Shanghai 200040, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of the above paper, the authors have realized that the cell apoptosis and cell proliferation assays in Fig. 8 were poorly presented, which made the interpretation of the data difficult. Furthermore, a change was also required to the text concerning the description of Fig. 8: The sentence starting on p. 517, left‑hand column, line 7 ('The fraction of apoptotic cells was 22.41±2.596 in the lncENST00000444102-overexpressing SKM‑1 cells, and 8.650±0.889 in the negative control; the fraction of apoptotic cells was 20.58±2.190 in the lncENST00000444102‑overexpressing THP‑1 cells and 8.192±0.997 in the negative control group (P<0.001, Fig. 8B)' should be replaced with the following text: 'Flow cytometry showed that the fraction of apoptotic cells increased in the lncENST00000444102‑overexpressing SKM‑1 and THP‑1 cells, as determined by Annexin V‑APC/7-AAD staining at 48 h (P<0.05; Fig. 8B)'. A revised version of Fig. 8, presenting the results of the flow cytometric analysis more clearly, is shown on the next page. Note that the revisions made to this figure have not had a major impact on the reported results, and do not affect the overall conclusions reported in the study. All the authors agree to the publication of this corrigendum. The authors are grateful to the Editor of

Indexed as

4‑aminobutyrate aminotransferaseABATco‑expression networklong non‑coding RNAsmicroarray analysismyelodysplastic syndrome

Identifiers

PMID35703350
PMCPMC9245076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.